Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
Trial design and data reporting The primary objective of this open-label, first-in-human, phase 1, three-arm umbrella trial (ClinicalTrials.gov:…
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy
Clinical samples and cohorts Supplementary Table 10 summarizes the different clinical cohorts used in this Article, and presents…